News

1 September 2011

SYN|thesis Med Chem Pty to provide medicinal chemistry services to Redx Pharma Ltd

SYN|thesis Med Chem Pty have signed an agreement with Liverpool-based pharmaceutical company Redx Pharma Ltd to provide contractual chemistry services. Medicinal chemistry will be carried out at SYN|thesis Med Chem facility in Shanghai, People's Republic of China with day-to-day project management via the Melbourne facility.

Dr Neil Murray, CEO at Redx Pharma, commented “SYN|thesis not only offers us cost effective chemistry resources but also brings a wealth of experience which we can leverage in our own programs, to help bring new treatments faster, cheaper and with more chance of market success”. Professor Andrew Wilks, Executive Chairman of SYN|thesis said “We are very much looking forward to working with Redx Pharma and the team. Their pioneering approach to the project, coupled with our medicinal chemistry expertise and flexible approach will make an exciting and productive combination”.